Skip to main content

Animations

MJFF Publications

2291 - 2300 of 6403 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2021
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000200222
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.107807
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Gait Analysis in Progressive Supranuclear Palsy Phenotypes
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.674495
    Citation Count: 15
  • Summary Details
    OPEN
    Title: CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
    Journal Name: Nature Immunology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41590-023-01604-z
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Automatic geometry-based estimation of the locus coeruleus region on T1-weighted magnetic resonance images
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2024.1375530
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00679-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00121-2
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Prospective Role of PAK6 and 14-3-3γ as Biomarkers for Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230402
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00758-3
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Visualizing chaperone-mediated multistep assembly of the human 20S proteasome
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-024-01268-9
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.